GLP-1 drugs, such as Ozempic and Wegovy, have become some of the most expensive prescription medications covered by Medicare. These drugs are widely used to treat type 2 diabetes and obesity by mimicking a natural hormone that regulates blood sugar and appetite. Their effectiveness in controlling diabetes and promoting weight loss has driven their popularity, but this surge in demand is also leading to skyrocketing costs for Medicare.

With the growing prevalence of diabetes among the aging population, Medicare’s budget is increasingly strained by the high costs of these medications. GLP-1 drugs, while proven effective, are creating financial challenges for the healthcare system, and spending is expected to rise even further in the coming years as more patients are prescribed these treatments.

How 360/Health Can Help

At 360/Health, we help you manage healthcare costs by providing tools to find affordable treatment options and stay informed about changes in healthcare coverage. Our platform empowers you to make smarter, cost-effective decisions about your medications and overall health.

For more insights into healthcare trends, read the full article on Healthcare Brew.